See every side of every news story
Published loading...Updated

Study Shows Anti-Aging Potential for Insilico's IPF Candidate

Summary by GEN - Genetic Engineering and Biotechnology News…
Researchers from artificial intelligence (AI) drug developer Insilico Medicine and two partner institutions have published a study concluding that its lead candidate ISM001-055 is the first to show anti-aging properties and that its mechanism of action offers a promising therapeutic approach for treating age-related diseases. ISM001-055 was shown to have attenuated cellular senescence through the suppression of various aging processes, thus show…

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

GEN - Genetic Engineering and Biotechnology News… broke the news in on Friday, February 21, 2025.
Sources are mostly out of (0)